US Patent 11053219 Substituted pyridines as TYK2 inhibitors
Patent 11053219 was granted and assigned to Esker Therapeutics on July, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11053219 Substituted pyridines as TYK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
